SCIENCE OF
POSSIBILITY
At Vertex, we invest in scientific innovation to create transformative medicines for people with serious diseases.
We have published our 2024 Corporate Responsibility Report
Vertex researcher receives the 2025 Canada Gairdner International Award for pioneering research and discovery of medicines for cystic fibrosis
We are announcing our Q1 2025 financial results on May 5
We've reported our fourth quarter and full year 2024 financial results
Our treatment for moderate-to-severe acute pain in adults is approved by the U.S. FDA
Working at Vertex
Our company is built on an inclusive culture that brings together the best and brightest in every field striving for one goal: to improve the lives of people with serious diseases.
Find a Vertex clinical trial
Volunteers who participate in clinical trials
help make new medicines a reality.
Featured Stories
We are relentless in our quest to improve the lives of people living with serious diseases. Thanks to the dedication of teams led by Paul Negulescu, our medicines have profoundly impacted the cystic fibrosis community, earning recognition such as the prestigious Canada Gairdner International Award.
Hear Emani McConnell-Brent's story with APOL1-mediated kidney disease (AMKD) and how she’s used her diagnosis to inspire and educate others on the importance of being an active participant in their own health.
The Vertex Foundation had a powerful year of impact in 2024. Learn how we continue to drive meaningful change in our communities.
We are relentless in our quest to improve the lives of people living with serious diseases. Thanks to the dedication of teams led by Paul Negulescu, our medicines have profoundly impacted the cystic fibrosis community, earning recognition such as the prestigious Canada Gairdner International Award.
Hear Emani McConnell-Brent's story with APOL1-mediated kidney disease (AMKD) and how she’s used her diagnosis to inspire and educate others on the importance of being an active participant in their own health.
The Vertex Foundation had a powerful year of impact in 2024. Learn how we continue to drive meaningful change in our communities.
